Technical Analysis for GBT - Global Blood Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 49.51 -5.71% -3.00
GBT closed down 5.71 percent on Friday, March 22, 2019, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
5 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Flat Down
See historical GBT trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Fell Below 50 DMA Bearish 0.00%
Mar 22 180 Bearish Setup Bearish Swing Setup 0.00%
Mar 22 Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Multiple of Ten Bearish Other 0.00%
Mar 22 BB Squeeze + Lower Band Touch Range Contraction 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%
Mar 21 Crossed Above 20 DMA Bullish -5.71%
Mar 21 Bollinger Band Squeeze Range Contraction -5.71%

Older signals for GBT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics to treat grievous blood-based disorders. Its product candidate is GBT440, a hemoglobin modifier that binds to hemoglobin molecules, which is in double-blind Phase I/II clinical trial indicated for the treatment of sickle cell disease. The company also focuses on developing an oral prophylactic therapy for hypoxemic pulmonary disorders and hereditary angioedema. The company was founded in 2011 and is based in South San Francisco, California.
Medicine Biopharmaceutical Medical Specialties Blood Hereditary Angioedema Angioedema Hemoglobin Sickle Cell Disease
Is GBT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Mar 8 Announcing: Global Blood Therapeutics (NASDAQ:GBT) Stock Increased An Energizing 211% In The Last Three Years
Mar 4 Detailed Research: Economic Perspectives on Intelsat S.A, Sprint, Restaurant Brands International, Tower Semiconductor, TE Connectivity, and Global Blood Therapeutics — What Drives Growth in Today's Competitive Landscape
Mar 4 GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference
Feb 28 Aiming at genetic diseases, Peninsula stealth biotech emerges with $191 million
Feb 27 Global Blood Therapeutics misses by $0.04
Feb 27 GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results
Feb 21 Biotechs under pressure, XBI down 1.4%
Feb 21 GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference
Feb 19 GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease
Feb 8 Global Blood Therapeutics: A Crucial Year Ahead
See more GBT news...
Indicators
Indicator Value
52 Week High 54.88
52 Week Low 30.15
Average Volume 641,784
200-Day Moving Average 43.4317
50-Day Moving Average 49.7302
20-Day Moving Average 51.9455
10-Day Moving Average 51.976
Average True Range 2.1224
ADX 19.16
+DI 17.8954
-DI 19.1689
Chandelier Exit (Long, 3 ATRs ) 48.5128
Chandelier Exit (Short, 3 ATRs ) 54.4572
Upper Bollinger Band 54.4956
Lower Bollinger Band 49.3954
Percent B (%b) 0.02
BandWidth 9.818367
MACD Line 0.5063
MACD Signal Line 0.8526
MACD Histogram -0.3463
Fundamentals Value
Market Cap 2.16 Billion
Num Shares 43.7 Million
EPS -2.46
Price-to-Earnings (P/E) Ratio -20.13
Price-to-Sales 0.00
Price-to-Book 5.19
PEG Ratio -0.38
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 54.12
Resistance 3 (R3) 54.55 53.45 53.35
Resistance 2 (R2) 53.45 52.28 53.23 53.09
Resistance 1 (R1) 51.48 51.55 50.93 51.05 52.84
Pivot Point 50.38 50.38 50.11 50.16 50.38
Support 1 (S1) 48.41 49.21 47.86 47.98 46.18
Support 2 (S2) 47.31 48.48 47.09 45.93
Support 3 (S3) 45.34 47.31 45.67
Support 4 (S4) 44.91